1. Home
  2. Analysis
  3. Isosorbide-mononitrate
  4. Cefoxitin

Isosorbide mononitrate and Cefoxitin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Isosorbide mononitrate (isosorbide mononitrate) and Cefoxitin (cefoxitin sodium). Common drug interactions include blood glucose increased among females and blood glucose increased among males.

The phase IV clinical study analyzes what interactions people have when they take Isosorbide mononitrate and Cefoxitin. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Isosorbide mononitrate?

Isosorbide mononitrate has active ingredients of isosorbide mononitrate. It is often used in angina. eHealthMe is studying from 26,858 Isosorbide mononitrate users. Check the latest studies of Isosorbide mononitrate.

What is Cefoxitin?

Cefoxitin has active ingredients of cefoxitin sodium. eHealthMe is studying from 611 Cefoxitin users. Check the latest studies of Cefoxitin.

On Apr, 19, 2026

20 people who take Isosorbide mononitrate and Cefoxitin together, and have interactions are studied.

Isosorbide mononitrate and Cefoxitin drug interactions.

What are the common drug interactions of Isosorbide Mononitrate and Cefoxitin, by gender? *:

female:

  1. Blood glucose increased
  2. Blood magnesium decreased
  3. Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
  4. Aspartate aminotransferase increased
  5. Blood albumin decreased
  6. Blood calcium decreased
  7. Blood chloride increased
  8. Blood phosphorus decreased
  9. Blood potassium decreased
  10. Chills (felling of cold)

male:

  1. Blood glucose increased
  2. Haemoglobin decreased
  3. Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
  4. Supraventricular extrasystoles (premature electrical impulse in the heart, generated above the level of the ventricle)
  5. Abdominal distension
  6. Abdominal infection
  7. Abdominal pain
  8. Cholecystitis (infection of gallbladder)
  9. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
  10. Hyperlipidaemia (presence of excess lipids in the blood)

What are the common drug interactions of Isosorbide Mononitrate and Cefoxitin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Complications of transplanted kidney
  2. Urine output decreased

30-39:

  1. Blood glucose increased
  2. Lymphocyte count decreased
  3. Blood albumin decreased
  4. Blood calcium decreased
  5. Blood chloride increased
  6. Aspartate aminotransferase increased
  7. Blood magnesium decreased
  8. Blood phosphorus decreased
  9. Blood potassium decreased
  10. Chills (felling of cold)

40-49:

  1. Abdominal pain lower
  2. Abnormal sensation in eye
  3. Bilirubin conjugated increased
  4. Blood bilirubin increased
  5. Blood creatinine increased
  6. Blood glucose increased
  7. Blood magnesium decreased
  8. Blood urea increased
  9. Blood urine present
  10. Haemoglobin decreased

50-59:

  1. Blood albumin decreased
  2. Abdominal infection
  3. Abdominal pain
  4. Cholecystitis (infection of gallbladder)
  5. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
  6. Hyperlipidaemia (presence of excess lipids in the blood)
  7. Intestinal obstruction
  8. Urinary tract infection
  9. Lymphocyte count increased
  10. Blood calcium decreased

60+:

  1. Encephalopathy (functioning of the brain is affected by some agent or condition)

What are the existing conditions these people have? *

  1. High Blood Pressure: 19 people, 95.00%
  2. Anaesthesia: 18 people, 90.00%
  3. Nausea And Vomiting: 16 people, 80.00%
  4. Cardiac Disorder: 16 people, 80.00%
  5. Constipation: 15 people, 75.00%
  6. Diarrhea: 14 people, 70.00%
  7. Hepatic Function Abnormal: 13 people, 65.00%
  8. Urination - Excessive Volume: 12 people, 60.00%
  9. Blood Glucose Increased: 11 people, 55.00%
  10. Infection: 10 people, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Isosorbide mononitrate and Cefoxitin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Isosorbide mononitrate and Cefoxitin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Isosorbide mononitrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cefoxitin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Isosorbide mononitrate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefoxitin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on isosorbide mononitrate and cefoxitin sodium (the active ingredients of Isosorbide mononitrate and Cefoxitin, respectively), and Isosorbide mononitrate and Cefoxitin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.